Metropolitan Life Insurance Company (MetLife)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-581
| Closed | -$8.58K | – | 2296 |
|
|
2024
Q1 | $8.58K | Hold |
581
| – | – | ﹤0.01% | 2183 |
|
|
2023
Q4 | $7.79K | Hold |
581
| – | – | ﹤0.01% | 2249 |
|
|
2023
Q3 | $7.16K | Hold |
581
| – | – | ﹤0.01% | 2350 |
|
|
2023
Q2 | $7.15K | Buy |
+581
| New | +$7.15K | ﹤0.01% | 2424 |
|
|
2017
Q2 | – | Sell |
-11,830
| Closed | -$287K | – | 2612 |
|
|
2017
Q1 | $287K | Buy |
11,830
+723
| +7% | +$17.5K | ﹤0.01% | 2036 |
|
|
2016
Q4 | $357K | Sell |
11,107
-723
| -6% | -$23.2K | ﹤0.01% | 1964 |
|
|
2016
Q3 | $591K | Sell |
11,830
-34
| -0.3% | -$1.7K | ﹤0.01% | 1596 |
|
|
2016
Q2 | $503K | Buy |
11,864
+337
| +3% | +$14.3K | ﹤0.01% | 1694 |
|
|
2016
Q1 | $759K | Buy |
11,527
+1,752
| +18% | +$115K | 0.01% | 1316 |
|
|
2015
Q4 | $608K | Buy |
9,775
+290
| +3% | +$18K | ﹤0.01% | 1502 |
|
|
2015
Q3 | $635K | Sell |
9,485
-356
| -4% | -$23.8K | ﹤0.01% | 1476 |
|
|
2015
Q2 | $957K | Buy |
9,841
+407
| +4% | +$39.6K | 0.01% | 1319 |
|
|
2015
Q1 | $882K | Hold |
9,434
| – | – | 0.01% | 1272 |
|
|
2014
Q4 | $839K | Hold |
9,434
| – | – | 0.01% | 1446 |
|
|
2014
Q3 | $652K | Hold |
9,434
| – | – | ﹤0.01% | 1543 |
|
|
2014
Q2 | $541K | Hold |
9,434
| – | – | ﹤0.01% | 1778 |
|
|
2014
Q1 | $374K | Hold |
9,434
| – | – | ﹤0.01% | 2006 |
|
|
2013
Q4 | $396K | Hold |
9,434
| – | – | ﹤0.01% | 1977 |
|
|
2013
Q3 | $282K | Hold |
9,434
| – | – | ﹤0.01% | 2157 |
|
|
2013
Q2 | $500K | Buy |
+9,434
| New | +$500K | ﹤0.01% | 1696 |
|